18.27MMarket Cap
LossP/E TTM
Dare Bioscience Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Dare Bioscience Inc is 8.43, ranking 57 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is -1.35, which is -145.12% below the recent high of 0.61 and -1319.84% above the recent low of -19.13.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.